Tofacitinib is Effective in Psoriatic Arthritis
This agent was superior to placebo in patients who had not responded to or could not take a conventional DMARD.
Golimumab FDA Approved for Psoriatic Arthritis, Ankylosing Spondylitis
This is the only fully human anti-TNF-α infused therapy approved for psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis.
Physicians Forgo Psoriatic Arthritis Treatment Adjustments
Residual disease activity is common, and treatment options abound, but for most patients changes are not being made.
Psoriatic Arthritis Damage Marked by Enthesitis Severity
Sonographic enthesitis severity is a potential marker of radiographic peripheral and axial joint damage.
Orencia Gains Psoriatic Arthritis Approval in Europe
Patients demonstrated improved disease response in 2 clinical trials.
7 Treatment Guidelines for Knee and Hip Replacement Surgery
In this slideshow, we highlight newly released treatment recommendations for rheumatic disease patients undergoing total hip or total knee arthroplasty.
New Antirheumatic Drug Guidelines for Hip and Knee Arthroplasty
Rheumatic patients are more prone to complications post knee and hip surgery. Two physician associations have penned new treatment guidelines.
Rethinking Pain Management in Psoriatic Arthritis
EULAR 20017: Despite the use of biologic therapy, pain ranging from mild to severe is a persistent problem for psoriatic arthritis patients, researchers reported at EULAR 2017.
The Role of Innate Lymphoid Cells in Inflammatory Rheumatic Disease
Innate lymphoid cells have a clear role in rheumatic disease and its related inflammatory process.
Biosimilar Proves to be OK for Switching
Clinical trial shows that switching from the infliximab originator to its biosimilar does not compromise safety or effectiveness of treatment.